StockData
Scienture Holdings, Inc. logo

Scienture Holdings, Inc. (SCNX) stock

SCNXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 16, 2026Score 3/30
$2.28−0.16 (-6.45%)

Close on Nov 20, 2026Market cap $4.07MP/E –Yield –

Scienture free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Scienture's free cash flow for the twelve months ending Dec 31, 2024 was -$14.28M. For fiscal 2024 it was -$14.28M.

Annual free cash flow

PeriodPeriod endValueChange
FY2024Dec 31, 2024-$14.28M–
FY2021Dec 31, 2021-$2.59M–
FY2020Dec 31, 2020-$2.25M–
FY2013Dec 31, 2013-$855.57K–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2024Dec 31, 2024-$2.91M–
Q4 FY2020Dec 31, 2020-$729.54K–
Q3 FY2020Sep 30, 2020$2.48M–

More Scienture figures

See a number that looks wrong?